O. Patthey-Vuadens

The Anticancer Drug Tamoxifen Counteracts the Pathology in a Mouse Model of Duchenne Muscular Dystrophy

O.M. Dorchies, Julie Reutenauer-Patte, Elyes Dahmane et al. · American Journal Of Pathology · 2013 · 111 citations · Full text

Medicine, Oncology, Pharmacology +15

Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic<i>mdx</i>mouse, a model for Duchenne muscular dystrophy

J. Reutenauer, O.M. Dorchies, O. Patthey-Vuadens et al. · British Journal of Pharmacology · 2008 · 98 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Melatonin improves muscle function of the dystrophic mdx5Cv mouse, a model for Duchenne muscular dystrophy

Youssef Hibaoui, Julie Reutenauer-Patte, O. Patthey-Vuadens et al. · Journal of Pineal Research · 2011 · 59 citations

Medicine, Biochemistry, Pharmacology +16

Caloric restriction induces energy-sparing alterations in skeletal muscle contraction, fiber composition and local thyroid hormone metabolism that persist during catch-up fat upon refeeding

Paula B M De Andrade, L. Neff, Miriam Štrosová et al. · Frontiers in Physiology · 2015 · 46 citations · Full text

Life Sciences, Nutritional Sciences, Physiology +15

Urocortins Improve Dystrophic Skeletal Muscle Structure and Function through Both PKA- and Epac-Dependent Pathways

Julie Reutenauer-Patte, François‐Xavier Boittin, O. Patthey-Vuadens et al. · American Journal Of Pathology · 2011 · 41 citations · Full text

Life Sciences, Neurobiology, Physiology +8